Tigran Kostanyan1, Tarek Shazly1, Kevin B Kaplowitz2, Steven Z Wang1, Sushma Kola1, Eric N Brown3, Nils A Loewen4,5. 1. Department of Ophthalmology, University of Pittsburgh, Pittsburgh, PA, USA. 2. Department of Ophthalmology, VA Loma Linda, Loma Linda University, Loma Linda, CA, USA. 3. Department of Ophthalmology, Vanderbilt University Medical Center, Nashville, TN, USA. 4. Department of Ophthalmology, University of Pittsburgh, Pittsburgh, PA, USA. loewen.nils@gmail.com. 5. Department of Ophthalmology, School of Medicine, University of Pittsburgh, 203 Lothrop St, Pittsburgh, PA, 15213, USA. loewen.nils@gmail.com.
Abstract
PURPOSE: To apply propensity score matching to compare Baerveldt glaucoma drainage implant (BGI) to Trabectome-mediated ab interno trabeculectomy (AIT). Recent data suggests that AIT can produce results similar to BGI which is traditionally reserved for more severe glaucoma. METHODS: BGI and AIT patients with at least 1 year of follow-up were included. The primary outcome measures were intraocular pressure (IOP), number of glaucoma medications, and a Glaucoma Index (GI) score. GI reflected glaucoma severity based on visual field, the number of preoperative medications, and preoperative IOP. Score matching used a genetic algorithm consisting of age, gender, type of glaucoma, concurrent phacoemulsification, baseline number of medications, and baseline IOP. Patients with neovascular glaucoma, with prior glaucoma surgery, or without a close match were excluded. RESULTS: Of 353 patients, 30 AIT patients were matched to 29 BGI patients. Baseline characteristics including, IOP, the number of glaucoma medications, type of glaucoma, the degree of VF loss and GI were not significantly different between AIT and BGI. BGI had a preoperative IOP of 21.6 ± 6.3 mmHg compared to 21.5 ± 7.4 for AIT on 2.8 ± 1.1 medications and 2.5 ± 2.3 respectively. At 30 months, the mean IOP was 15.0 ± 3.9 mmHg for AIT versus 15.0 ± 5.7 mmHg for BGI (p > 0.05), while the number of drops was 1.5 ± 1.3 for AIT (change: p = 0.001) versus 2.4 ± 1.2 for BGI (change: p = 0.17; AIT vs BGI: 0.007). Success, defined as IOP < 21 mmHg, < 20% reduction and no reoperation, was achieved at 1 year in 56% of AIT versus 55% of BGI (p > 0.05) and 50% versus 52% at 2.5 years. CONCLUSIONS: A propensity score matched comparison of AIT and BGI demonstrated a similar IOP reduction through 1 year. AIT required fewer medications.
PURPOSE: To apply propensity score matching to compare Baerveldt glaucoma drainage implant (BGI) to Trabectome-mediated ab interno trabeculectomy (AIT). Recent data suggests that AIT can produce results similar to BGI which is traditionally reserved for more severe glaucoma. METHODS: BGI and AIT patients with at least 1 year of follow-up were included. The primary outcome measures were intraocular pressure (IOP), number of glaucoma medications, and a Glaucoma Index (GI) score. GI reflected glaucoma severity based on visual field, the number of preoperative medications, and preoperative IOP. Score matching used a genetic algorithm consisting of age, gender, type of glaucoma, concurrent phacoemulsification, baseline number of medications, and baseline IOP. Patients with neovascular glaucoma, with prior glaucoma surgery, or without a close match were excluded. RESULTS: Of 353 patients, 30 AIT patients were matched to 29 BGI patients. Baseline characteristics including, IOP, the number of glaucoma medications, type of glaucoma, the degree of VF loss and GI were not significantly different between AIT and BGI. BGI had a preoperative IOP of 21.6 ± 6.3 mmHg compared to 21.5 ± 7.4 for AIT on 2.8 ± 1.1 medications and 2.5 ± 2.3 respectively. At 30 months, the mean IOP was 15.0 ± 3.9 mmHg for AIT versus 15.0 ± 5.7 mmHg for BGI (p > 0.05), while the number of drops was 1.5 ± 1.3 for AIT (change: p = 0.001) versus 2.4 ± 1.2 for BGI (change: p = 0.17; AIT vs BGI: 0.007). Success, defined as IOP < 21 mmHg, < 20% reduction and no reoperation, was achieved at 1 year in 56% of AIT versus 55% of BGI (p > 0.05) and 50% versus 52% at 2.5 years. CONCLUSIONS: A propensity score matched comparison of AIT and BGI demonstrated a similar IOP reduction through 1 year. AIT required fewer medications.
Authors: Panos G Christakis; Jeffrey W Kalenak; James C Tsai; David Zurakowski; Jeffrey A Kammer; Paul J Harasymowycz; Juan J Mura; Louis B Cantor; Iqbal I K Ahmed Journal: Ophthalmology Date: 2016-08-17 Impact factor: 12.079
Authors: Thomas Wecker; Matthias Neuburger; Laura Bryniok; Kathrin Bruder; Jan Luebke; Alexandra Anton; Jens F Jordan Journal: J Glaucoma Date: 2016-09 Impact factor: 2.503
Authors: Hardik A Parikh; Ralitsa T Loewen; Pritha Roy; Joel S Schuman; Kira L Lathrop; Nils A Loewen Journal: Sci Rep Date: 2016-11-04 Impact factor: 4.379
Authors: Ralitsa T Loewen; Pritha Roy; Hardik A Parikh; Yalong Dang; Joel S Schuman; Nils A Loewen Journal: PLoS One Date: 2016-03-23 Impact factor: 3.240
Authors: Ralitsa T Loewen; Eric N Brown; Gordon Scott; Hardik Parikh; Joel S Schuman; Nils A Loewen Journal: Invest Ophthalmol Vis Sci Date: 2016-05-01 Impact factor: 4.799
Authors: A Strzalkowska; P Strzalkowski; Y Al Yousef; F Grehn; J Hillenkamp; Nils A Loewen Journal: Graefes Arch Clin Exp Ophthalmol Date: 2020-12-02 Impact factor: 3.117